248 related articles for article (PubMed ID: 22920385)
1. FDG PET/CT of a benign ovarian Brenner tumor.
Toriihara A; Taniguchi Y; Negi M; Kubota K; Makino T; Shibuya H
Clin Imaging; 2012; 36(5):650-3. PubMed ID: 22920385
[TBL] [Abstract][Full Text] [Related]
2. Malignant ovarian Brenner tumor. A case report evaluated with (18)F-FDG PET/CT.
Mena LM; Carmona E; Maza FR; Guiote MV; Moreno E; Vallejo JA
Rev Esp Med Nucl Imagen Mol; 2015; 34(5):337-8. PubMed ID: 25890890
[No Abstract] [Full Text] [Related]
3. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
[TBL] [Abstract][Full Text] [Related]
4. Spectrum of fluorodeoxyglucose-positron emission tomography/computed tomography and magnetic resonance imaging findings of ovarian tumors.
Kitajima K; Ueno Y; Maeda T; Murakami K; Kaji Y; Kita M; Suzuki K; Sugimura K
Jpn J Radiol; 2011 Nov; 29(9):605-8. PubMed ID: 21956364
[TBL] [Abstract][Full Text] [Related]
5. [PET/CT scan with (18)F-FDG in re-staging of an atypical case of ovarian cancer].
García Gómez FJ; Cuenca Cuenca JI; Acevedo Báñez I; Borrego Dorado I; Calvo García E; Vázquez Albertino RJ
Rev Esp Med Nucl Imagen Mol; 2012; 31(4):223-4. PubMed ID: 23067691
[No Abstract] [Full Text] [Related]
6. The performance of contrast-enhanced FDG PET/CT for the differential diagnosis of unexpected ovarian mass lesions in patients with nongynecologic cancer.
Lee JW; Lee JH; Cho A; Yun M; Lee JD; Kim YT; Kang WJ
Clin Nucl Med; 2015 Feb; 40(2):97-102. PubMed ID: 25546187
[TBL] [Abstract][Full Text] [Related]
7. 18F-FDG PET/CT and MR findings of ovarian carcinoid within a dermoid cyst.
Horikawa M; Shinmoto H; Soga S; Miyai K; Kaji T
Clin Nucl Med; 2014 Sep; 39(9):e392-4. PubMed ID: 24300346
[TBL] [Abstract][Full Text] [Related]
8. A singular observation of a giant benign Brenner tumor of the ovary.
Ruggiero S; Ripetti V; Bianchi A; La Vaccara V; Alloni R; Coppola R
Arch Gynecol Obstet; 2011 Aug; 284(2):513-6. PubMed ID: 21594602
[TBL] [Abstract][Full Text] [Related]
9. FDG-PET/CT as a molecular biomarker in ovarian cancer.
Nowosinska E; Avril S; Murray I; Szyszko T; Avril N
Cancer Biomark; 2010-2011; 8(4-5):167-75. PubMed ID: 22045351
[TBL] [Abstract][Full Text] [Related]
10. Unilateral ovarian metastasis from gastric mucinous adenocarcinoma visualized on FDG PET/CT.
Tamam MO; Mulazimoglu M; Kamali G; Eker O; Ozpacaci T
Eur Rev Med Pharmacol Sci; 2012 Oct; 16 Suppl 4():1-3. PubMed ID: 23090794
[TBL] [Abstract][Full Text] [Related]
11. Leydig cell tumour of the ovary localised with positron emission tomography/computed tomography.
Prassopoulos V; Laspas F; Vlachou F; Efthimiadou R; Gogou L; Andreou J
Gynecol Endocrinol; 2011 Oct; 27(10):837-9. PubMed ID: 21668318
[TBL] [Abstract][Full Text] [Related]
12. FDG PET/CT in serous psammocarcinoma of the ovary.
Dong A; Wang Y; Zuo C
Clin Nucl Med; 2014 May; 39(5):453-5. PubMed ID: 23510884
[TBL] [Abstract][Full Text] [Related]
13. Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125.
Rubini G; Altini C; Notaristefano A; Merenda N; Rubini D; Ianora AA; Asabella AN
Rev Esp Med Nucl Imagen Mol; 2014; 33(1):22-7. PubMed ID: 23948509
[TBL] [Abstract][Full Text] [Related]
14. [CT features of ovarian Brenner tumor and a report of 9 cases].
Wang XY; Dai JR; Zhu Z; Zhao YF; Zhou CW
Zhonghua Zhong Liu Za Zhi; 2010 May; 32(5):359-62. PubMed ID: 20723434
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
16. The role of FDG-PET/CT in ovarian cancer patients with high tumor markers or suspicious lesion on contrast-enhanced CT in evaluation of recurrence and/or in determination of intraabdominal metastases.
Sari O; Kaya B; Kara PO; Gedik GK; Celik C; Ozbek O; Serdengecti M
Rev Esp Med Nucl Imagen Mol; 2012; 31(1):3-8. PubMed ID: 21549452
[TBL] [Abstract][Full Text] [Related]
17. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
18. Physiologic FDG uptake in the ovary together with an abdominal wall leiomyoma mimicking metastasizing ovarian cancer on PET/CT imaging.
Schwarz EI; Ramach C; Mende KA; Strobel K
Clin Nucl Med; 2009 Apr; 34(4):249-50. PubMed ID: 19300062
[TBL] [Abstract][Full Text] [Related]
19. Malignant Brenner tumor with transition from benign to malignant components: computed tomographic and magnetic resonance imaging findings with pathological correlation.
Takeuchi M; Matsuzaki K; Sano N; Furumoto H; Nishitani H
J Comput Assist Tomogr; 2008; 32(4):553-4. PubMed ID: 18664841
[TBL] [Abstract][Full Text] [Related]
20. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R
J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
